Elsevier

Asian Journal of Psychiatry

Volume 18, December 2015, Pages 75-80
Asian Journal of Psychiatry

Comparative trial of the WHO ASSIST-linked brief intervention and simple advice for substance abuse in primary care

https://doi.org/10.1016/j.ajp.2015.09.003Get rights and content

Highlights

  • We screened primary care patients with the ASSIST.

  • We compared the effect of the ASSIST-linked brief intervention and simple advice.

  • Both brief intervention and simple advice decreased drug use for six months.

  • Our study supports the benefit of early intervention of drug misuse in primary care.

Abstract

To help decrease the burden of substance-related problems, the World Health Organization developed the Alcohol, Smoking, Substance Involvement Screening Test (ASSIST) – a sensitive screening questionnaire to help identify misuse of alcohol and other substances – linked to Brief Intervention (BI). This paper compares the effectiveness of the ASSIST followed either by its linked BI or by simple advice (SA). The trial was conducted in southern Thailand. The ASSIST was used to screen patients attending primary care units and categorise them into ‘low-risk’, ‘moderate-risk’ and ‘high-risk’ groups. Patients at ‘moderate-risk’ were randomised to receive ASSIST-linked BI (n = 120) or SA (n = 116). The outcome measures were changes in the ASSIST-Specific Substance Involvement Scores (ASSIST-SSIS), ASSIST-Total Substance Involvement Scores (ASSIST-TSIS) and proportions of patients whose scores at three and six months had decreased from the ‘moderate-risk’ to ‘low-risk’ category. 147 patients (72 BI; 75 SA) completed the six-month trial. There were significant reductions in both ASSIST-SSIS and ASSIST-TSIS, with no significant difference between groups. The percentages of patients converted to the ‘low-risk’ category were 36.7% and 38.8% at month 3, and 53.3% and 53.4% at month 6, for the BI and SA groups, respectively. In conclusion, in primary care administering the ASSIST and telling patients their score, followed either by formal brief intervention or simple advice, are equally effective in decreasing substance use for up to six months.

Introduction

Substance misuse is a worldwide problem, accounting for much morbidity and mortality (Lim et al., 2012, Degenhardt et al., 2013, World Health Organization, 2014). Most substance users do not seek treatment even when it is available. A national household survey in Thailand in 2011 revealed that only 0.57% of participants who reported using alcohol, tobacco or illicit drugs had received previous treatment for their substance use (Administrative Committee on Substance Abuse Academic Network, 2012). Routine screening for alcohol and other substance use in primary healthcare could increase this figure by engaging in treatment non-dependent abusers seeking help for other reasons (Nilsen, 2010).

Most previous studies of screening and brief counselling were of alcohol and tobacco users and the results suggested that the interventions are effective in decreasing the use of these substances (Jonas et al., 2012). However, the evidence for other drugs is scant.

To help decrease the public health burden of substance-related problems, the World Health Organization (WHO) developed the Alcohol, Smoking, Substance Involvement Screening Test (ASSIST), a sensitive screening questionnaire to help identify misuse of alcohol and a wide range of substances, that is linked to Brief Intervention (BI) (WHO ASSIST Working Group, 2002, Humeniuk et al., 2010). Humenick et al. (2012) demonstrated in a multi-country study that primary care patients receiving the BI had significantly reduced ASSIST scores, compared with waiting-list control participants, over the course of three months.

The aims of the study reported in this paper were to assess the effectiveness of the WHO ASSIST-BI procedure compared with ASSIST-screening followed by simple advice (SA) in primary care in low-population areas of southern Thailand, and to determine if any changes shown were maintained for three and six months after treatment.

Section snippets

Ethics

The trial was implemented according to Good Clinical Practice guidelines and the protocol and materials were approved by the Ethics Committee (EC) for Research in Human Subjects, Faculty of Medicine, Prince of Songkla University.

The procedure at all stages was fully explained to patients and written permission to participate was obtained. In the case of participants aged 16–17 years, written consent was obtained from them directly, as they came to the hospitals unaccompanied and were unwilling

Participants

Of 775 eligible patients attending clinics during the study period, 747 agreed to be screened with the ASSIST and 55, 498 and 194 of them were categorised into the ‘high-’, ‘moderate-’ and ‘low-risk’ groups, respectively. Of the 498 ‘moderate-risk’ patients, 262 were excluded because they used tobacco only, leaving 236 to be randomised to receive brief intervention or simple advice (Fig. 1).

Most participants were men, aged 16 to 25 (60.7%), had secondary school education (12 years of study in

Main findings

Our study is one of the few randomised controlled trials that assessed the longer-term effects of ASSIST-linked Brief Intervention in primary care. The results showed that alcohol and other substance use risk scores decreased significantly over time in both the intervention and control groups, with no significant difference between groups. There were also no significant between-group differences in proportions of participants who changed to the ‘low-risk’ category and in frequency of substance

Conclusions

Our findings suggest that screening with the ASSIST followed by its linked brief intervention (taking on average 8 min), or the same screening followed by simple advice (average 4 min), do not have significantly different effects in decreasing alcohol and other substance use over three and six month periods. The finding is important in screening large numbers of patients in specialties where time is limited and where the difference between 8 and 4 min, although small, can be the main factor in

Role of funding source

The study was supported by the Integrated Community Management for Substance Abuse Programme (I-MAP) of the Thai Health Promotion Foundation [54-02-003]. The Epidemiology Unit is partially supported by the National Science and Technology Development Agency (P-10-10307), Ministry of Science and Technology, Thailand. JGE's contributions incurred no fees or expenses.

Contributors

SA and PN conceived and designed the study with advice from JGE; PN collected data; PN and EM analysed the data; each author interpreted the data and contributed to the drafting of the manuscript.

Conflict of interest statement

None declared.

Acknowledgements

We thank the staff in district and sub-district hospitals and study participants for their collaboration. We also express our appreciation to the WHO Collaborating Centre for Research in the Treatment of Drug and Alcohol Problems, Drug and Alcohol Services South Australia, University of Adelaide, for providing training on the ASSIST-BI process and other technical assistance.

References (19)

There are more references available in the full text version of this article.

Cited by (0)

Web address of the trial registration: http://www.ANZCTR.org.au/ACTRN12613000080729.aspx; Trial ID: ACTRN12613000080729; Date submitted: 11/08/2012; Date registered: 22/01/2013. The full protocol of the trial is available on request from the corresponding author.

View full text